Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14911)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 28, 2014 (publication date) through Apr 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Soresi M, Giannitrapani L, Cervello M, Licata A, Montalto G. Non invasive tools for the diagnosis of liver cirrhosis. World J Gastroenterol 2014; 20(48): 18131-18150 [PMID: 25561782 DOI: 10.3748/wjg.v20.i48.18131] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i48/18131.htm |
| Number | Citing Articles |
| 1 |
Nicole M. Hindman, Hina Arif-Tiwari, Ihab R. Kamel, Waddah B. Al-Refaie, Twyla B. Bartel, Brooks D. Cash, Victoria Chernyak, Alan Goldstein, Joseph R. Grajo, Jeanne M. Horowitz, Aya Kamaya, Michelle M. McNamara, Kristin K. Porter, Pavan K. Srivastava, Atif Zaheer, Laura R. Carucci. ACR Appropriateness Criteria® Jaundice. Journal of the American College of Radiology 2019; 16(5): S126 doi: 10.1016/j.jacr.2019.02.012
|
| 2 |
Se Yoon Park, Shi Nae Yu, Eun Jung Lee, Tark Kim, Min Hyok Jeon, Eun Ju Choo, Suyeon Park, Joon Won Chae, Hae In Bang, Tae Hyong Kim. Monomicrobial gram-negative necrotizing fasciitis: An uncommon but fatal syndrome. Diagnostic Microbiology and Infectious Disease 2019; 94(2): 183 doi: 10.1016/j.diagmicrobio.2018.12.013
|
| 3 |
Randhall B Carteri, Mateus Grellert, Daniela Luisa Borba, Claudio Augusto Marroni, Sabrina Alves Fernandes. Machine learning approaches using blood biomarkers in non-alcoholic fatty liver diseases. Artificial Intelligence in Gastroenterology 2022; 3(3): 80-87 doi: 10.35712/aig.v3.i3.80
|
| 4 |
Davide Roccarina, Richard G. Barr. Multiparametric Ultrasound for the Assessment of Diffuse Liver Disease. 2024; : 125 doi: 10.1016/B978-0-323-87479-3.00017-X
|
| 5 |
Jianbo Jian, Xinyan Zhao, Lili Qin, Yuqing Zhao, Mengyu Sun, Wenjuan Lv, Chunhong Hu. Three-dimensional visualization of fibrous tissues in cirrhotic rats via X-ray phase-contrast computed tomography with iodine staining. Journal of Synchrotron Radiation 2019; 26(4): 1354 doi: 10.1107/S1600577519006064
|
| 6 |
Malgorzata Pawlowska, Malgorzata Sobolewska-Pilarczyk, Krzysztof Domagalski. Hepatitis C virus infection in children in the era of direct-acting antiviral. World Journal of Gastroenterology 2018; 24(24): 2555-2566 doi: 10.3748/wjg.v24.i24.2555
|
| 7 |
Stanislav Listopad, Christophe Magnan, Le Z. Day, Aliya Asghar, Andrew Stolz, John A. Tayek, Zhang-Xu Liu, Jon M. Jacobs, Timothy R. Morgan, Trina M. Norden-Krichmar, Nicole Yee-Key Li-Jessen. Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning. PLOS Digital Health 2024; 3(2): e0000447 doi: 10.1371/journal.pdig.0000447
|
| 8 |
Hitoshi Maruyama, Gamal Shiha, Osamu Yokosuka, Ashish Kumar, Barjesh Chander Sharma, Alaa Ibrahim, Vivek Saraswat, Cosmas Rinaldi A. Lesmana, Masao Omata. Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography. Hepatology International 2016; 10(2): 267 doi: 10.1007/s12072-015-9670-9
|
| 9 |
Anna Licata, Maria Giovanna Minissale, Filippo A. Montalto, Maurizio Soresi. Is vitamin D deficiency predictor of complications development in patients with HCV-related cirrhosis?. Internal and Emergency Medicine 2019; 14(5): 735 doi: 10.1007/s11739-019-02072-w
|
| 10 |
Sweta Chekuri, Jillian Nickerson, Kian Bichoupan, Roberta Sefcik, Kamini Doobay, Sanders Chang, David DelBello, Alyson Harty, Douglas T. Dieterich, Ponni V. Perumalswami, Andrea D. Branch, Ratna B. Ray. Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus. PLOS ONE 2016; 11(7): e0159413 doi: 10.1371/journal.pone.0159413
|
| 11 |
Ahmet Öz, Tufan Çınar, Ebru Taş, Süleyman Çağan Efe, Burak Ayça, Turgut Karabağ. Assessment of pulmonary arterial stiffness in patients with cirrhosis: A prospective cohort study. Echocardiography 2021; 38(1): 57 doi: 10.1111/echo.14935
|
| 12 |
Xiangbo Meng, Zhengqi Pan, Jiawei Zhao, Quansheng Feng. Efficacy and safety of Fufang Biejia Ruangan Tablets as an adjuvant treatment for chronic hepatitis B liver fibrosis: A systematic review and meta-analysis. Medicine 2022; 101(46): e31664 doi: 10.1097/MD.0000000000031664
|
| 13 |
J Qiao. Occurrence, diagnosis and management of hepatic fibrosis and cirrhosis: An updated literature review. Archives of Hepatitis Research 2019; 5(1): 022 doi: 10.17352/ahr.000023
|
| 14 |
Asmaa Salama Sieddek, Mohamed Kamal Taha, Dina Attia. Fibrosis-4 (FIB-4) Score Reduction in Chronic Hepatitis C Cirrhotic Patients Treated with Direct Acting Antiviral Agents. SN Comprehensive Clinical Medicine 2023; 5(1) doi: 10.1007/s42399-022-01363-2
|
| 15 |
Peter Robert Coombs, Mengistu Warsa, Tadiwos Hailu, Eskzyiaw Agedew, Behailu Tsegaye. Establishing an Ultrasound Screening Protocol for Chronic Liver Disease with a Handheld Device: A Pilot Project in Southern Ethiopia. Ultrasound in Medicine & Biology 2022; 48(4): 702 doi: 10.1016/j.ultrasmedbio.2021.12.013
|
| 16 |
Gina Gheorghe, Simona Bungău, Gabriela Ceobanu, Mădălina Ilie, Nicolae Bacalbaşa, Ovidiu Gabriel Bratu, Cosmin Mihai Vesa, Mihnea-Alexandru Găman, Camelia Cristina Diaconu. The non-invasive assessment of hepatic fibrosis. Journal of the Formosan Medical Association 2021; 120(2): 794 doi: 10.1016/j.jfma.2020.08.019
|
| 17 |
G. Soker, A. Bahadir Ozturk, B. Gulek, F. Kuscu, U. Bilge Doğan, C. Yilmaz. Doppler ultrasonography helps discriminate between cirrhotic and non-cirrhotic patients with viral B and C hepatitis. Diagnostic and Interventional Imaging 2016; 97(3): 339 doi: 10.1016/j.diii.2015.05.014
|
| 18 |
Hiroto Kayashima, Takashi Maeda, Noboru Harada, Takanobu Masuda, Atsushi Guntani, Shuhei Ito, Ayumi Matsuyama, Motohiro Hamatake, Shinichi Tsutsui, Hiroyuki Matsuda, Teruyoshi Ishida. Risk factors for incisional hernia after hepatic resection for hepatocellular carcinoma in patients with liver cirrhosis. Surgery 2015; 158(6): 1669 doi: 10.1016/j.surg.2015.06.001
|
| 19 |
Zhongji Meng, Yonghong Zhang, Zhiqiang Wei, Ping Liu, Jian Kang, Yinhua Zhang, Deqiang Ma, Changzheng Ke, Yue Chen, Jie Luo, Zuojiong Gong. High serum resistin associates with intrahepatic inflammation and necrosis: an index of disease severity for patients with chronic HBV infection. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-016-0558-5
|
| 20 |
Ahmed A. Ghafar, Elsayed Ghoneem, Ramy H. Agwa, Ahmed Akef, Ahmad S. H. Hasan, Nahed Abdallah. Value of serum fibronectin for assessment of liver fibrosis in chronic hepatitis C virus patients. The Egyptian Journal of Internal Medicine 2019; 31(4): 465 doi: 10.4103/ejim.ejim_46_19
|
| 21 |
Taha Aghajanzadeh, Mahmood Talkhabi, Mohammad Reza Zali, Behzad Hatami, Kaveh Baghaei. Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis. Non-coding RNA Research 2023; 8(4): 471 doi: 10.1016/j.ncrna.2023.06.004
|
| 22 |
Shinya Yokoyama, Yoji Ishizu, Takashi Honda, Norihiro Imai, Takanori Ito, Kenta Yamamoto, Tomoyuki Tsuzuki, Masatoshi Ishigami. Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis. Hepatology Research 2022; 52(2): 199 doi: 10.1111/hepr.13725
|
| 23 |
Reham M. Dawood, Mai Abd el-Meguid, Marwa K. Ibrahim, Noha G. Bader El Din, Ahmed Barakat, Khaled El-Wakeel, Mohamed Darwish Ahmed Abd Alla, George Y. Wu, Mostafa K. El Awady. Dysregulation of fibrosis related genes in HCV induced liver disease. Gene 2018; 664: 58 doi: 10.1016/j.gene.2018.04.032
|
| 24 |
Mònica Pons, Macarena Simón-Talero, Laura Millán, Meritxell Ventura-Cots, Begoña Santos, Salvador Augustin, Joan Genescà. Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease. Digestive and Liver Disease 2016; 48(10): 1214 doi: 10.1016/j.dld.2016.06.019
|
| 25 |
I. V. Dvoryakovskiy, S. A. Ivleva, Galina M. Dvoryakovskaya, A. N. Surkov, A. S. Potapov, I. E. Smirnov. Modern technologies of ultrasound diagnostics of cirrhosis in chronic liver diseases in children. Russian Pediatric Journal 2019; 19(4): 202 doi: 10.18821/1560-9561-2016-19-4-202-208
|
| 26 |
Xin Jin, Bin Fu, Zheng-Jie Wu, Xiao-Qin Zheng, Jian-Hua Hu, Lin-Feng Jin, Ling-Ling Tang. Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China. Hepatobiliary & Pancreatic Diseases International 2020; 19(4): 384 doi: 10.1016/j.hbpd.2020.05.009
|
| 27 |
Jeong Hyun Lee, Ijin Joo, Tae Wook Kang, Yong Han Paik, Dong Hyun Sinn, Sang Yun Ha, Kyunga Kim, Choonghwan Choi, Gunwoo Lee, Jonghyon Yi, Won-Chul Bang. Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network. European Radiology 2020; 30(2): 1264 doi: 10.1007/s00330-019-06407-1
|
| 28 |
Julian A. Luetkens, Sebastian Nowak, Narine Mesropyan, Wolfgang Block, Michael Praktiknjo, Johannes Chang, Christian Bauckhage, Rafet Sifa, Alois Martin Sprinkart, Anton Faron, Ulrike Attenberger. Deep learning supports the differentiation of alcoholic and other-than-alcoholic cirrhosis based on MRI. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-12410-2
|
| 29 |
Antonio Murgia, Yusuf Ahmed, Kelly Sweeney, Louise Nicholson-Scott, Kayleigh Arthur, Max Allsworth, Billy Boyle, Olga Gandelman, Agnieszka Smolinska, Giuseppe Ferrandino. Breath-Taking Perspectives and Preliminary Data toward Early Detection of Chronic Liver Diseases. Biomedicines 2021; 9(11): 1563 doi: 10.3390/biomedicines9111563
|
| 30 |
Florian Weber, Tommaso Casalini, Gina Valentino, Lorine Brülisauer, Nico Andreas, Andreas Koeberle, Thomas Kamradt, Alessandro Contini, Paola Luciani. Targeting transdifferentiated hepatic stellate cells and monitoring the hepatic fibrogenic process by means of IGF2R-specific peptides designed in silico. Journal of Materials Chemistry B 2021; 9(8): 2092 doi: 10.1039/D0TB02372H
|
| 31 |
Rekha Kishore, Rohit Loomba, Richard K Sterling. Editorial: A New Spin on Magnetic Resonance Elastography. American Journal of Gastroenterology 2016; 111(6): 834 doi: 10.1038/ajg.2016.134
|
| 32 |
Jingxin Zhao, Fei Zhai, Jun Cheng, Qiong He, Jianwen Luo, Xueping Yang, Jinhua Shao, Huichun Xing, Jee-Fu Huang. Evaluating the Significance of Viscoelasticity in Diagnosing Early-Stage Liver Fibrosis with Transient Elastography. PLOS ONE 2017; 12(1): e0170073 doi: 10.1371/journal.pone.0170073
|
| 33 |
Michael A. Fischer, Katharina Brehmer, Anders Svensson, Peter Aspelin, Torkel B. Brismar. Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension. European Radiology 2016; 26(11): 4030 doi: 10.1007/s00330-016-4277-7
|
| 34 |
Mrigendra B. Karmacharya, Laith R. Sultan, Brooke M. Kirkham, Angela K. Brice, Andrew K.W. Wood, Chandra M. Sehgal. Photoacoustic Imaging for Assessing Tissue Oxygenation Changes in Rat Hepatic Fibrosis. Diagnostics 2020; 10(9): 705 doi: 10.3390/diagnostics10090705
|
| 35 |
Byeong Geun Song, Tae Wook Kang, Dong Hyun Sinn, Yeun-Yoon Kim, Ji Hye Min, Jeong Ah. Hwang, Jaeseung Shin. Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics. Clinical Imaging 2024; 108: 110097 doi: 10.1016/j.clinimag.2024.110097
|
| 36 |
Amany A. Sayed, Amel M. Soliman, Mohamed Marzouk, Faten F. Mohammed, Shreen Desouky. Bromelain mitigates liver fibrosis via targeting hepatic stellate cells in vitro and in vivo. Tissue and Cell 2023; 82: 102118 doi: 10.1016/j.tice.2023.102118
|
| 37 |
Bin Zhang, Long Liang, Yuhao Dong, Zhouyang Lian, Wenbo Chen, Changhong Liang, Shuixing Zhang, Peter Starkel. Intravoxel Incoherent Motion MR Imaging for Staging of Hepatic Fibrosis. PLOS ONE 2016; 11(1): e0147789 doi: 10.1371/journal.pone.0147789
|
| 38 |
Andrejs Ernests Zirnis, Zane Straume, Raisa Bērziņa, Justīne Māliņa-Bambīte, Aleksejs Derovs, Inese Zeltiņa. Establishing Cut-Offs for Non-Invasive Liver Tests to Detect Cirrhosis at a High Sensitivity. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2020; 74(2): 118 doi: 10.2478/prolas-2020-0019
|
| 39 |
Marco Sanduzzi-Zamparelli, Zoe Mariño, Sabela Lens, Victor Sapena, Gemma Iserte, Anna Pla, Núria Granel, Concepció Bartres, Neus Llarch, Ramón Vilana, Isabel Nuñez, Anna Darnell, Ernest Belmonte, Angeles García-Criado, Alba Díaz, Sergio Muñoz-Martinez, Carmen Ayuso, Luis Bianchi, Carla Fuster-Anglada, Jordi Rimola, Alejandro Forner, Ferran Torres, Jordi Bruix, Xavier Forns, Maria Reig. Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules. Journal of Hepatology 2022; 76(4): 874 doi: 10.1016/j.jhep.2021.11.023
|
| 40 |
Neil D. Theise, Henry Charles Bodenheimer, Maria Guido. Macsween's Pathology of the Liver. 2018; : 372 doi: 10.1016/B978-0-7020-6697-9.00006-6
|
| 41 |
Krishna Sumanth Nallagangula, Shashidhar Kurpad Nagaraj, Lakshmaiah Venkataswamy, Muninarayana Chandrappa. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression. Future Science OA 2018; 4(1): FSO250 doi: 10.4155/fsoa-2017-0083
|
| 42 |
Ben L. Da, Pallavi Surana, David E. Kleiner, Theo Heller, Christopher Koh. The Delta-4 fibrosis score (D4FS): A novel fibrosis score in chronic hepatitis D. Antiviral Research 2020; 174: 104691 doi: 10.1016/j.antiviral.2019.104691
|
| 43 |
|
| 44 |
Qian Wang, Feng Ye, Peiqing Ma, Yiqun Che, Weilan Guo, Dong Yan, Xinming Zhao. Quantified MRI and 25OH-VitD3 can be used as effective biomarkers for patients with neoadjuvant chemotherapy-induced liver injury in CRCLM?. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07282-6
|
| 45 |
Caroline Lefeuvre, Marine Roux, Simon Blanchard, Hélène Le Guillou-Guillemette, Jérôme Boursier, Françoise Lunel-Fabiani, Pascale Jeannin, Adeline Pivert, Alexandra Ducancelle. Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14285-9
|
| 46 |
A. N. Katrich, S. V. Polshikov, A. M. Kurilskaya. Value of radiology techniques for diagnosis of obstructive jaundice in admission department. Innovative medicine of Kuban 2020; (3): 68 doi: 10.35401/2500-0268-2020-19-3-68-76
|
| 47 |
Yang Liu, Guillaume Méric, Aki S. Havulinna, Shu Mei Teo, Fredrik Åberg, Matti Ruuskanen, Jon Sanders, Qiyun Zhu, Anupriya Tripathi, Karin Verspoor, Susan Cheng, Mohit Jain, Pekka Jousilahti, Yoshiki Vázquez-Baeza, Rohit Loomba, Leo Lahti, Teemu Niiranen, Veikko Salomaa, Rob Knight, Michael Inouye. Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting. Cell Metabolism 2022; 34(5): 719 doi: 10.1016/j.cmet.2022.03.002
|
| 48 |
Young Woo Eom, Soon Koo Baik. Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C. Clinical and Molecular Hepatology 2019; 25(1): 37 doi: 10.3350/cmh.2018.1011
|
| 49 |
Amr Shaaban Hanafy, Mohamed Abdel Khalik Basha, Fady Maher Wadea. Novel markers of endothelial dysfunction in hepatitis C virus-related cirrhosis: More than a mere prediction of esophageal varices. World Journal of Hepatology 2020; 12(10): 850-862 doi: 10.4254/wjh.v12.i10.850
|
| 50 |
Joseph Redman, Richard K. Sterling. Non-invasive Assessment of Liver Fibrosis. Current Treatment Options in Gastroenterology 2020; 18(2): 255 doi: 10.1007/s11938-020-00285-z
|
| 51 |
Anne-Marieke Van Dijk, Yasaman Vali, Anne Linde Mak, Jenny Lee, Maarten E. Tushuizen, Mohammad Hadi Zafarmand, Quentin M. Anstee, M. Julia Brosnan, Max Nieuwdorp, Patrick M. Bossuyt, Adriaan G. Holleboom. Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2021; 10(13): 2910 doi: 10.3390/jcm10132910
|
| 52 |
Fathima Shihana, Mugdha V. Joglekar, Tae-Hwi Schwantes-An, Anandwardhan A. Hardikar, Devanshi Seth. MicroRNAs Signature Panel Identifies Heavy Drinkers with Alcohol-Associated Cirrhosis from Heavy Drinkers without Liver Injury. Biology 2023; 12(10): 1314 doi: 10.3390/biology12101314
|
| 53 |
Zheng Fang, Weifeng Hu, Mengyi Wang, Renbin Wang, Shuo Zhong, Siyuan Chen. X-ray absorption spectroscopy combined with machine learning for diagnosis of schistosomiasis cirrhosis. Biomedical Signal Processing and Control 2020; 60: 101944 doi: 10.1016/j.bspc.2020.101944
|
| 54 |
Frank Czul, Kalyan R. Bhamidimarri. Noninvasive Markers to Assess Liver Fibrosis. Journal of Clinical Gastroenterology 2016; 50(6): 445 doi: 10.1097/MCG.0000000000000534
|
| 55 |
Kang Li, Ling Qin, Sanjie Jiang, Ang Li, Chi Zhang, Guihai Liu, Jianping Sun, Huanqing Sun, Yan Zhao, Ning Li, Yonghong Zhang. The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation. Clinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-00847-z
|
| 56 |
Suk Keu Yeom, Chang Hee Lee, Sang Hoon Cha, Cheol Min Park. Prediction of liver cirrhosis, using diagnostic imaging tools. World Journal of Hepatology 2015; 7(17): 2069-2079 doi: 10.4254/wjh.v7.i17.2069
|
| 57 |
Laura Hickman, Lauren Tanner, John Christein, Selwyn Vickers. Non-Hepatic Abdominal Surgery in Patients with Cirrhotic Liver Disease. Journal of Gastrointestinal Surgery 2019; 23(3): 634 doi: 10.1007/s11605-018-3991-7
|
| 58 |
Ankita Singh, Vipul Ranjan, Rina Das, Karun Bhatti, Dinesh Kumar Mehta, Ram Mohan Chidurala. Serum Biomarkers for Noninvasive Diagnosis of Liver Diseases: How Laudable are These Tools?. Current Chemical Biology 2021; 15(2): 128 doi: 10.2174/2212796814999201111204639
|
| 59 |
Mayur Virarkar, Ajaykumar C. Morani, Melissa W. Taggart, Priya Bhosale. Liver Fibrosis Assessment. Seminars in Ultrasound, CT and MRI 2021; 42(4): 381 doi: 10.1053/j.sult.2021.03.003
|
| 60 |
Luciano Tarantino, Pasquale Ambrosino, Matteo Nicola Dario Di Minno. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(32): 9457-9460 doi: 10.3748/wjg.v21.i32.9457
|
| 61 |
Anna Sheptulina, Elena Shirokova, Tatiana Nekrasova, Hubert Blum, Vladimir Ivashkin. Platelet count to spleen diameter ratio non‐invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis. Journal of Gastroenterology and Hepatology 2016; 31(12): 1956 doi: 10.1111/jgh.13407
|
| 62 |
Stephanie Van Biervliet, Hugo Verdievel, Saskia Vande Velde, Ruth De Bruyne, Danny De Looze, Xavier Verhelst, Anja Geerts, Eddy Robberecht, Hans Van Vlierberghe. Longitudinal Transient Elastography Measurements Used in Follow-up for Patients with Cystic Fibrosis. Ultrasound in Medicine & Biology 2016; 42(4): 848 doi: 10.1016/j.ultrasmedbio.2015.11.011
|
| 63 |
Mina Hur, Mikyoung Park, Hee-Won Moon, Won Hyeok Choe, Chae Hoon Lee. Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer. Annals of Laboratory Medicine 2022; 42(2): 249 doi: 10.3343/alm.2022.42.2.249
|